MARC Record from marc_columbia

LEADER: 02356cam a2200469 i 4500
001 3913444
005 20221027000702.0
008 841108s1979 gw a b 100 0 eng
010 $a 79125999
020 $a0387092919
035 $a(OCoLC)6917151
035 $a(OCoLC)ocm06917151
035 $a(CStRLIN)NYCM84-B3171
035 $9ADG5733HS
035 $a(NNC)3913444
035 $a3913444
040 $dNNC-M
050 00 $aRC261$b.R35 no. 67, vol. 1$aRC270.8
082 0 $a616.99/4 s$a616.99/4$219
110 2 $aEuropean Organization for Research on Treatment of Cancer.$0http://id.loc.gov/authorities/names/n79056809
245 10 $aMarkers and general problems of cancer adjuvant therapies /$cedited by G. Bonadonna, G. Mathé, S. E. Salmon. With 64 figures and 40 tables.
260 $aBerlin ;$aNew York :$bSpringer-Verlag,$c1979.
300 $axviii, 150 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aRecent results in cancer research ;$v67
490 1 $aIts Adjuvant therapies and markers of post-surgical minimal residual disease ; 1
500 $a"1978 annual plenary meeting of the European Organization for Research on Treatment of Cancer, Paris, June 1978."
500 $a"Sponsored by Swiss League against Cancer."
504 $aIncludes bibliographies.
650 0 $aCancer$xAdjuvant treatment$vCongresses.$0http://id.loc.gov/authorities/subjects/sh2008005053
650 0 $aTumor proteins$vCongresses.
650 2 $aNeoplasms$xtherapy.$0https://id.nlm.nih.gov/mesh/D009369Q000628
650 2 $aNeoplasm Proteins.$0https://id.nlm.nih.gov/mesh/D009363
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aBonadonna, G.,$d1934-$0http://id.loc.gov/authorities/names/n79016633
700 1 $aMathé, Georges.$0http://id.loc.gov/authorities/names/n79011206
700 1 $aSalmon, S. E.$q(Sydney E.),$d1936-$0http://id.loc.gov/authorities/names/n79034800
710 2 $aSchweizerische Nationalliga für Krebsbekämpfung und Krebsforschung.$0http://id.loc.gov/authorities/names/n79032131
830 0 $aAdjuvant therapies and markers of post-surgical minimal residual disease ;$v1.
830 0 $aRecent results in cancer research ;$v67.$0http://id.loc.gov/authorities/names/n42020830
852 00 $boff,hsl$hRC270.8$iEu72 1979